These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2273518)

  • 1. Safety issues related to DMARD therapy.
    Fries JF
    J Rheumatol Suppl; 1990 Nov; 25():14-7. PubMed ID: 2273518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of antirheumatic medications in children with juvenile arthritis.
    Furst DE
    J Rheumatol Suppl; 1992 Apr; 33():11-5. PubMed ID: 1593595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From aspirin to biologics: therapeutic implications for rheumatoid arthritis.
    Wright V
    J Rheumatol Suppl; 1992 Jan; 32():95-7. PubMed ID: 1613740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of conventional drugs and biologic agents for Rheumatoid Arthritis.
    Amoroso A; Gigante A; Gianni C; Amoroso D; Zennaro D; Galluzzo S; Caccavo D
    Eur Rev Med Pharmacol Sci; 2003; 7(5):139-45. PubMed ID: 15214589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term drug treatment of chronic polyarthritis: current status and perspectives].
    Wollenhaupt J; Langer HE
    Wien Med Wochenschr; 1990 Jun; 140(12):324-33. PubMed ID: 2204217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is a disease modifying antirheumatic drug?
    Hepburn B
    J Rheumatol Suppl; 1988 Sep; 16():40-2. PubMed ID: 2903926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of disease-modifying antirheumatic drugs (DMARDs) in the therapy of rheumatoid arthritis].
    Cervini C; Salaffi F; Peroni M
    Clin Ter; 1993 Jan; 142(1):3-18. PubMed ID: 8472508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reevaluating the therapeutic approach to rheumatoid arthritis: the "sawtooth" strategy.
    Fries JF
    J Rheumatol Suppl; 1990 May; 22():12-5. PubMed ID: 2192055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reevaluation of aspirin therapy in rheumatoid arthritis.
    Fries JF; Ramey DR; Singh G; Morfeld D; Bloch DA; Raynauld JP
    Arch Intern Med; 1993 Nov; 153(21):2465-71. PubMed ID: 8215751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of action of disease modifying antirheumatic drugs.
    Harth M
    J Rheumatol Suppl; 1992 Jan; 32():100-3. PubMed ID: 1613728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease modifying antirheumatic drugs: longterm safety issues.
    Capell HA
    J Rheumatol Suppl; 2001 Jun; 62():10-5. PubMed ID: 11409152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of rheumatoid arthritis: current and future].
    Bentin J
    Rev Med Brux; 1993 Jun; 14(6):175-81. PubMed ID: 8367633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of drug use in rheumatoid arthritis.
    Bérard A; Solomon DH; Avorn J
    J Rheumatol; 2000 Jul; 27(7):1648-55. PubMed ID: 10914846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the toxicity of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Furst DE
    J Rheumatol; 1991 Feb; 18(2):159-60. PubMed ID: 2023208
    [No Abstract]   [Full Text] [Related]  

  • 16. ARAMIS and toxicity measurement. (Arthritis Rheumatism and Aging Medical Information System).
    Fries JF
    J Rheumatol; 1995 May; 22(5):995-7. PubMed ID: 8587097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use and abuse of antirheumatic drugs in chronic arthritis].
    Berglund K
    Lakartidningen; 1977 Dec; 74(50):4493-5. PubMed ID: 304131
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenging the therapeutic pyramid: a new look at treatment strategies for rheumatoid arthritis.
    Wilske KR; Healey LA
    J Rheumatol Suppl; 1990 Nov; 25():4-7. PubMed ID: 2273521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions.
    Blomqvist P; Feltelius N; Ekbom A; Klareskog L
    J Rheumatol; 2000 May; 27(5):1171-7. PubMed ID: 10813283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts.
    Emery P; Luqmani R; Gordon C
    Br J Clin Pract; 1994; 48(2):82-6. PubMed ID: 7912952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.